ES540748A0 - Un procedimiento para la preparacion de nuevos 2,5-diaril-tetrahidrotiofenos y analogos de los mismos. - Google Patents

Un procedimiento para la preparacion de nuevos 2,5-diaril-tetrahidrotiofenos y analogos de los mismos.

Info

Publication number
ES540748A0
ES540748A0 ES540748A ES540748A ES540748A0 ES 540748 A0 ES540748 A0 ES 540748A0 ES 540748 A ES540748 A ES 540748A ES 540748 A ES540748 A ES 540748A ES 540748 A0 ES540748 A0 ES 540748A0
Authority
ES
Spain
Prior art keywords
tetrahidrotiofenos
diaril
analogs
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES540748A
Other languages
English (en)
Other versions
ES8607274A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES8607274A1 publication Critical patent/ES8607274A1/es
Publication of ES540748A0 publication Critical patent/ES540748A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78Separation; Purification; Stabilisation; Use of additives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
ES540748A 1984-02-29 1985-02-27 Un procedimiento para la preparacion de nuevos 2,5-diaril-tetrahidrotiofenos y analogos de los mismos. Expired ES8607274A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58469384A 1984-02-29 1984-02-29

Publications (2)

Publication Number Publication Date
ES8607274A1 ES8607274A1 (es) 1986-05-16
ES540748A0 true ES540748A0 (es) 1986-05-16

Family

ID=24338431

Family Applications (1)

Application Number Title Priority Date Filing Date
ES540748A Expired ES8607274A1 (es) 1984-02-29 1985-02-27 Un procedimiento para la preparacion de nuevos 2,5-diaril-tetrahidrotiofenos y analogos de los mismos.

Country Status (12)

Country Link
EP (1) EP0154887B1 (es)
JP (1) JPS60208975A (es)
AU (1) AU574436B2 (es)
CA (1) CA1266271A (es)
DE (1) DE3567865D1 (es)
DK (1) DK91885A (es)
ES (1) ES8607274A1 (es)
GR (1) GR850505B (es)
IL (1) IL74376A (es)
NZ (1) NZ211146A (es)
PT (1) PT79996B (es)
ZA (1) ZA851519B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5010100A (en) * 1983-11-14 1991-04-23 Merck & Co. Inc. Certain 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
US4757084A (en) * 1984-02-29 1988-07-12 Merck & Co., Inc. 2,5-diaryl tetrahydrothiophenes and analogs thereof as PAF-antagonists
DE3873278T2 (de) * 1987-09-22 1993-02-25 Merck & Co Inc Aryl-substituierte thiophen-3-ole, ihre derivate und analoge als lipoxygenase-inhibitoren.
US4999436A (en) * 1987-09-22 1991-03-12 Merck & Co., Inc. Aryl-substituted thiophene 3-ols, derivatives and analogs useful as lipoxgenase inhibitors
US4996203A (en) * 1987-12-21 1991-02-26 Merck & Co., Inc. 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
ATE84724T1 (de) * 1988-04-27 1993-02-15 Schering Corp Gewisse paf-antagonist/antihistamin-mischungen und verfahren.
US5334592A (en) * 1988-04-27 1994-08-02 Schering Corporation Certain PAF antagonist antihistamine combinations and methods
EP0365089A3 (en) * 1988-10-18 1991-06-05 Merck & Co. Inc. 2-aryl-5(3-methoxy-5-(hydroxypropylsulfonyl)-4-propoxyphenyl) tetrahydrothiophen and analogs
US5021586A (en) * 1989-03-31 1991-06-04 Miles, Inc. Dithiophenylpyrrole derivative monomers for preparing semi-conducting polymers
US5011847A (en) * 1989-06-08 1991-04-30 Merck & Co., Inc. 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
US5114961A (en) * 1989-06-08 1992-05-19 Merck & Co., Inc. 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
US5001123A (en) * 1989-06-08 1991-03-19 Merck & Co., Inc. 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
JP2805006B2 (ja) * 1991-08-29 1998-09-30 財団法人 工業技術研究院 チオフェン系化合物及びその薬理的に許容できる塩類よりなる医薬
HUT77773A (hu) * 1994-06-27 1998-08-28 Cytomed Inc. Tetrahidrofuránszármazékok, azokat hatóanyagként tartalmazó gyógyszerkészítmények és alkalmazásuk gyógyszerkészítmények előállítására

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1271082A (en) * 1968-05-07 1972-04-19 Wyeth John & Brother Ltd Furan, pyrrole and thiophene derivatives
CA1086643A (en) * 1976-06-01 1980-09-30 Douglas I. Relyea Thiophenes useful in control of certain arthropods
AU550928B2 (en) * 1979-08-09 1986-04-10 Du Pont Merck Pharmaceutical Company, The 5-bromo-2,3-diarylthiophenes
EP0087629B1 (en) * 1982-03-03 1986-01-15 E.I. Du Pont De Nemours And Company Antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes

Also Published As

Publication number Publication date
PT79996B (en) 1987-01-13
ZA851519B (en) 1986-10-29
AU574436B2 (en) 1988-07-07
GR850505B (es) 1985-06-26
DK91885A (da) 1985-08-30
EP0154887A1 (en) 1985-09-18
EP0154887B1 (en) 1989-01-25
PT79996A (en) 1985-03-01
ES8607274A1 (es) 1986-05-16
NZ211146A (en) 1987-10-30
DE3567865D1 (en) 1989-03-02
AU3919485A (en) 1985-09-05
DK91885D0 (da) 1985-02-28
IL74376A0 (en) 1985-05-31
IL74376A (en) 1989-02-28
CA1266271A (en) 1990-02-27
JPS60208975A (ja) 1985-10-21

Similar Documents

Publication Publication Date Title
ES555834A0 (es) Un procedimiento para la preparacion de nuevas piranopiridinas.
ES545464A0 (es) Un procedimiento para la preparacion de tetrahidroftalimidas.
ES540705A0 (es) Un procedimiento para la preparacion de 17b-carbamoil-n-monosustituido -o 17b-acil-4-aza-5-alfa-androstien-3-onas.
ES556738A0 (es) Un procedimiento para la preparacion de nuevos piridazinaminas.
ES548073A0 (es) Un procedimiento para la preparacion de derivados de tiazol 2,4-disustituidos
ES540609A0 (es) Un procedimiento para la preparacion de pirazolo piridinas.
ES540610A0 (es) Un procedimiento para la preparacion de pirazolopiridinas.
ES544521A0 (es) Un procedimiento para la preparacion de triazolobenzodiazefinas.
ES546872A0 (es) Un procedimiento para la preparacion de aminoalcoxibenzopiranonas.
ES551564A0 (es) Un procedimiento para la preparacion de nuevas 1,4-dihidropiridinas
ES557076A0 (es) Un procedimiento para la preparacion de nuevas benzamidas sustituidas.
ES541781A0 (es) Un procedimiento para la preparacion de nuevos benzotiopenos.
ES540748A0 (es) Un procedimiento para la preparacion de nuevos 2,5-diaril-tetrahidrotiofenos y analogos de los mismos.
ES536683A0 (es) Un procedimiento para la preparacion de nuevos cinamil-2,3-dihidro-benzofuranos sustituidos y sus analagos.
ES547805A0 (es) Un procedimiento para la preparacion de nuevos derivados de guanina.
ES545574A0 (es) Un procedimiento para la preparacion bihidropiridanonas triciclicas.
ES539543A0 (es) Un procedimiento para la preparacion de nuevos compuestos de oxadiazinona.
ES496485A0 (es) Un procedimiento para la preparacion de nuevos 1,2,4-triazo-les
ES547205A0 (es) Un procedimiento para la preparacion de nuevas quinazolindionas.
ES528225A0 (es) Un procedimiento para la preparacion de nuevos derivados de 1,2,5,-tidiazol.
ES492115A0 (es) Un procedimiento para la preparacion de 10, 11-dihidro-5-h- dibenzo (a,d) ciclohepten -5,10-iminas
ES542882A0 (es) Un procedimiento para la preparacion de nuevas sulfonilureas.
ES545439A0 (es) Un procedimiento para la preparacion de 2-bencil-4-(4-piridil)-tiazoles.
ES510286A0 (es) "un procedimiento para la preparacion de nuevas fluoro-prostaciclinas".
ES541450A0 (es) Un procedimiento para la preparacion de nuevas espiro-3-heteroazolidindionas.